USPTO serial 75033385
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
| Class | Description | Status | First use |
|---|---|---|---|
| 017 | multi-purpose elastomeric-type hose for industrial use, namely, for transporting air or water | ABANDONED | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| May 21, 1998 | ABN3 | ABANDONMENT - AFTER EX PARTE APPEAL | — |
| May 21, 1998 | EXFB | EXPARTE APPEAL DISMISSED - FAILURE TO FILE BRIEF | — |
| Jan 20, 1998 | EXPT | EXPARTE APPEAL TERMINATED | — |
| Oct 29, 1997 | CNCF | CONTINUATION OF FINAL REFUSAL MAILED | — |
| Oct 3, 1997 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 2, 1997 | JURT | JURISDICTION RESTORED TO EXAMINING ATTORNEY | — |
| Sep 30, 1997 | EXPI | EX PARTE APPEAL-INSTITUTED | — |
| Sep 26, 1997 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 6, 1997 | CNFR | FINAL REFUSAL MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Feb 26, 1997 | CNEA | EXAMINER'S AMENDMENT MAILED | — |
| Oct 18, 1996 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 19, 1996 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 1, 1996 | DOCK | ASSIGNED TO EXAMINER | — |